{"cluster": 48, "subcluster": 28, "abstract_summ": "Compared with normal weight patients, those who were overweight had 1.84-fold odds of developing severe COVID-19 (odds ratio [OR] 1.84, 95% CI 0.99-3.43, P = 0.05), while those who were obese were at 3.40-fold odds of developing severe disease (OR 3.40, 95% CI 1.40-2.86, P = 0.007), after adjusting for age, sex, epidemiological characteristics, days from disease onset to hospitalization, presence of hypertension, diabetes, cardiovascular disease, chronic obstructive pulmonary disease, liver disease and cancer, and drug used for treatment.Moreover, patients who required IMV, were more likely to have had heart disease (aOR 3.41; 95% CI:1.05\u201011.06), obesity (BMI=30\u201034.9 kg/m2) (aOR 6.85; 95% CI: 1.05\u201044.82) or severe obesity (BMI\u226535 kg/m2) (aOR 9.99; 95% CI:1.39\u201071.69).CONCLUSION: In our analysis, severe obesity (BMI \u226535 kg/m2) was associated with ICU admission, while history of heart disease and obesity (BMI \u226530 kg/m2) were independently associated with the use of IMV.As the severe acute respiratory syndrome coronavirus 2 may continue to spread worldwide, clinicians should pay close attention to obese patients, who should be carefully managed with prompt and aggressive treatment.In a multivariate analysis, severe obesity (BMI \u226535 kg/m2) was associated with ICU admission (aOR 5.39; 95% CI:1.13\u201025.64).", "title_summ": "Obesity is Associated with Increased Risk for Mortality Among Hospitalized Patients with COVID-19.COVID-19: Impact of Obesity and Diabetes in Disease SeverityClinical epidemiological analyses of overweight/obesity and abnormal liver function contributing to prolonged hospitalization in patients infected with COVID-19Association of Obesity with Disease Severity among Patients with COVID\u201019High prevalence of obesity in severe acute respiratory syndrome coronavirus\u20102 (SARS\u2010CoV\u20102) requiring invasive mechanical ventilationObesity prolongs the hospital stay in patients affected by COVID-19, and may impact on SARS-COV-2 sheddingObesity and COVID\u201019: an Italian snapshotObesity is associated with worse outcomes in COVID\u201019: Analysis of Early Data From New York CityObesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China.", "title_abstract_phrases": "Compared with normal weight patients, those who were overweight had 1.84-fold odds of developing severe COVID-19 (odds ratio [OR] 1.84, 95% CI 0.99-3.43, P = 0.05), while those who were obese were at 3.40-fold odds of developing severe disease (OR 3.40, 95% CI 1.40-2.86, P = 0.007), after adjusting for age, sex, epidemiological characteristics, days from disease onset to hospitalization, presence of hypertension, diabetes, cardiovascular disease, chronic obstructive pulmonary disease, liver disease and cancer, and drug used for treatment.Moreover, patients who required IMV, were more likely to have had heart disease (aOR 3.41; 95% CI:1.05\u201011.06), obesity (BMI=30\u201034.9 kg/m2) (aOR 6.85; 95% CI: 1.05\u201044.82) or severe obesity (BMI\u226535 kg/m2) (aOR 9.99; 95% CI:1.39\u201071.69).CONCLUSION: In our analysis, severe obesity (BMI \u226535 kg/m2) was associated with ICU admission, while history of heart disease and obesity (BMI \u226530 kg/m2) were independently associated with the use of IMV.As the severe acute respiratory syndrome coronavirus 2 may continue to spread worldwide, clinicians should pay close attention to obese patients, who should be carefully managed with prompt and aggressive treatment.COVID-19: Impact of Obesity and Diabetes in Disease SeverityBackground: The Coronavirus disease 2019 (COVID19) pandemic is straining the healthcare system, particularly for patients with severe outcomes who require admittance to the intensive care unit (ICU)."}